Targeting CREB for Cancer Therapy: Friend or Foe

By  

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 384-391

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signalling Pathways in Hepatocellular Carcinoma

By  

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 170-175

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting monocyte chemoattractant protein-1 signalling in disease

By Dawson Janet   Miltz Wolfgang   Mir Anis K   Wiessner Christoph  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 1, 2003-02 ,pp. : 35-48

Informa Healthcare

Access to resources Recommend Favorite

Targeting signalling pathways for the treatment of multiple myeloma

By Podar Klaus   Hideshima Teru   Chauhan Dharminder   Anderson Kenneth C  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 359-381

Informa Healthcare

Access to resources Recommend Favorite

Targeting MAPK Signalling: Prometheus' Fire or Pandora's Box?

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1885-1905

Bentham Science Publishers

Access to resources Recommend Favorite